Catheter Precision (VTAK) Shares Outstanding (Weighted Average) (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.1 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.1 million, down 93.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 93.73% YoY), and the FY2025 annual result was $1.4 million, up 726.05% from the prior year.
• Shares Outstanding (Weighted Average) declined to $1.1 million in Q1 2026 per VTAK's latest filing, from $1.4 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $668.5 million in Q3 2022 and troughed at $107952.0 in Q3 2024.
• A 5-year average of $103.9 million and a median of $1.1 million in 2026 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) surged 742771011.11% in 2022, then plunged 99.94% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.0 million in 2022, then gained by 6.81% to $1.1 million in 2023, then sank by 84.44% to $171774.0 in 2024, then soared by 726.05% to $1.4 million in 2025, then dropped by 19.9% to $1.1 million in 2026.
• Business Quant data shows VTAK's Shares Outstanding (Weighted Average) at $1.1 million in Q1 2026, $1.4 million in Q4 2025, and $1.3 million in Q3 2025.